Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, like the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to perform so might be grounds for compensation. Our lawyers are working tough to have those hurt by the drug the compensation they are entitled how to get off xarelto - http://www.privatisti.com/?p=23753 .<br><br> <br><br> Whilst bleeding is actually a widespread complication associated with anticoagulants, it has been alleged that Xarelto is much more dangerous than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This implies that, within the occasion of an emergency, individuals could be at risk for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.<br><br> <br><br> If you or perhaps a loved a single suffered a serious bleeding event soon after taking Xarelto, you may have legal recourse. For much more info, get in touch with us right now to possess your case reviewed, free of charge of charge.<br><br> Compensation Possibilities<br><br> <br><br> xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future health-related - https://Www.biggerpockets.com/search?utf8=%E2%9C%93&term=future%20health-related bills, lost wages, pain and suffering and, in circumstances of death, funeral expenditures. Furthermore, they're looking for punitive damages, that are normally awarded to punish the defendant and deter other businesses from acting similarly.<br><br> Why Are Lawsuits - http://Www.Dailymail.Co.uk/home/search.html?sel=site&searchPhrase=Lawsuits Getting Filed?<br><br> <br><br> Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br> <br><br> In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br> <br><br> The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br><br> The makers of the drug continue to market Xarelto as a secure anticoagulant option.<br><br> Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.<br><br> Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.<br><br> Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing unsafe clotting.<br><br> <br><br> Visit this page for more details on the alleged health risks of Xarelto.<br><br> Multidistrict Litigation Trial Dates Set<br><br> <br><br> The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.